CDiffControl Preventive treatment assessment

ASSUMPTIONS:

01.

The extra cost of treating a hospitalized C. Difficile patient, is estimated to be $25,000. We will use $20,000 in our calculations.

02.

We estimate there are 7.5 million patients admitted to U. S. hospitals annually, who fit our criteria of >=65 and taking antibiotics.

03.

A typical hospital with 50,000 annual admissions would have 12,000 target patients. 

04.

The C. Difficile infection rate in this group is between 2.5% and 5%. 

05.

Our CDiffControl preventive treatment costs $450 per patient and is presumed 90% effective.

 

market-potential-Immunimed

At the 5% infection rate and treating 12,000 patients at $450 each will cost $5.4M but will save (540 x $20,000) $10.8M, for a 2:1 payback. At the 2.5% infection rate, treatment cost is $5.4M while saving $5.4M or break even, while also likely saving over 15+ lives (normal mortality is 6% but typically higher in this age group).

 

Total market potential for this group of patients only in the USA is $3.4 B annually.

Scroll to Top